"Cellulose nanocrystals, one of the most abundant materials in nature, have attracted great attention in the biomedical community due to qualities such as supreme mechanical properties, biodegradability, biocompatibility and low density. In this research, we are interested in developing a bio-inspired material-by-design approach for cellulose-based composites with tailored interfaces and programmed microstructures that could provide an outstanding strength-to-weight ratio. After a preliminary study on some of the existing biomaterials, we have focused our research on studying the nanostructure and nanomechanics of the bamboo fiber, a cellulose-based biocomposite, designed by nature with remarkable strength-to-weight ratio (higher than steel and concrete). We have utilized atomistic simulations to investigate the mechanical properties and mechanisms of interactions between cellulose nanofibrils and the bamboo fiber matrix which is an intertwined hemicellulose and lignin called lignin-carbohydrate complex (LCC). Our results suggest that the molecular origin of the rigidity of bamboo fibers comes from the carbon-carbon or carbon-oxygen covalent bonds in the main chain of cellulose. In the matrix of bamboo fiber, hemicellulose exhibits larger elastic modulus and glass transition temperature than lignin whereas lignin shows greater tendency to adhere to cellulose nanofibrils. Consequently, the role of hemicellulose is found to enhance the thermodynamic properties and transverse rigidity of the matrix by forming dense hydrogen bond networks, and lignin is found to provide the strength of bamboo fibers by creating strong van der Waals forces between nanofibrils and the matrix. Our results show that the amorphous region of cellulose nanofibrils is the weakest interface in bamboo microfibrils. We also found out that water molecules enhance the mechanical properties of lignin (up to 10%) by filling voids in the system and creating hydrogen bond bridges between polymer chains. For hemicellulose, however, the effect is always regressive due to the destructive effect of water molecules on the hydrogen bond in hemicellulose dense structure. Therefore, the porous structure of lignin supports the matrix to have higher rigidity in the presence of water molecules. "

Healthcare providers often are faced with the challenge of determining an appropriate length of dual antiplatelet therapy (DAPT) for patients who have had percutaneous coronary intervention and stent placement. This is an especially challenging clinical decision for patients with drug-eluting stents, as several studies show different results when assessing risk and benefit.

Konsekutive Untersuchung bei therapiebedürftiger ungeschützer linker Hauptstammstenose. Vergleich Bypass-Operation versus interventioneller Versorgung (PCI) des linken Hauptstamms mit beschichteten Stents unter besonderer Berücksichtigung des Lebensalters und der Lebensqualität. Einschluss von 300 Patienten (95 PCI, 205 OP) im Zeitraum April 2004 - Dezember 2007. Vergleich von Patienten älter und jünger als 75 Jahre. Einschlusskriterien: ungeschütze Hauptstammstenose > 50%, Angina pectoris CCS II-III, Lebenserwartung > 1 Jahr, Notwendigkeit der Versorgung. Ausschlusskriterien: intakter Bypass auf linke Kranzarterie, Notwendigkeit der kombinierten Bypass- und Klappenoperation, ST-Hebungsinfarkt, klinische Instabilität. PCI mit beschichteten Stents (Sirolimus, Tacrolimus). Bypassoperation mit Herzlungenmaschine und am schlagenden Herzen. Primäre Endpunkte: Tod kardial und nicht kardial, Apoplex, Myokardinfarkt, Revaskularisation der Zielläsion (TLR). Sekundärer Endpunkt: Lebensqualität nach 6 Monaten. Höherer Euroscore und Parosnnet-Score in Gruppe > 75 Jahre. 100 % Erfolgrate bei der Indexprozedur (OP oder PCI). 12-Monats-Ergebisse: Keine Unterschiede Tod oder Myokardinfarkt. Nicht signifikante Erhöhung von Apoplexen in OP-Gruppe (6% versus 1 %). Signifikant höhere TLR-Rate in PCI-Gruppe (10,5% versus 1,5%). Ältere Patienten hatten in beiden Armen eine reduzierte körperliche Lebensqualität, sonst keine Unterschiede in beiden Altersgruppen und Therapiearmen. Die PCI des linken Hauptstamms ist eine Alternative bei sorgfältig selektierten Patienten, insbesondere älteren Patienten mit Komorbititäten. / Consecutive analysis of patients with unprotected left main stenosis in need of treatment either with coronary bypass graft or coronary intervention with drug eluting stents taking into consideration the age of the patients and their quality of life. We included 300 patients (95 PCI, 205 OP) from April 2004 - December 2007. Comparison of patients under 75 and over 75 years. Inclusion criteria: unprotected left main stenosis > 50%, angina pectoris CCS II-III, life expectation > 1 year, need of treatment. Exclusion criteria: intact bypass graft on left coronary artery, neccessity of combined bypass and valve operation, ST-elevation infarction, clinical instability.PCI with drug eluting stents (Sirolimus, Tacrolimus). Bypass operation with heart-lung machine and off-pump operation. Primary end points: non-cardiac and cardiac death, stroke, myocardial infarction, target lesion revascularisation. Secondary end point: quality of life at 6 months. Higher Euroscore and Parsonett Score in patient group > 75 years. 100 % success with index procedure (CABG or PCI). 12 month results: no difference at death rates or myocardial infarction. No significant increase of stroke in bypass-graft group (6% versus 1%). Significant higher TLR-rate in PCI-group (10.5% versus 1.5%). Older patients suffered from reduced physical heatlth in both therapy groups. No other difference in the two age groups and therapy groups. PCI of unprotected left main is a therapy option in selected patients, especially those with comorbitities.

With each heartbeat, major arteries experience circumferential expansion due to internal pressure changes. This pulsatile force is called cyclic strain and has been implicated in playing a pivotal role in the genetic regulation of vascular physiology and pathology. This dissertation investigates the hypothesis that in human umbilical vein endothelial cells (HUVEC), pathological levels of cyclic strain activate the c-Myc promoter, leading to c-Myc transcription and downstream gene induction. To determine expression and time-dependency of c-Myc in HUVEC, mRNA and protein expression of c-Myc under physiological (6-10% cyclic strain) and pathological conditions (20% cyclic strain) were studied. Both c-Myc mRNA and protein expression increased more than three-fold in HUVEC (P4-P5) cyclically-strained at 20%. This expression occurred in a time-dependent manner, peaking in the 1.5-2 hour range and falling to basal levels by 3 hours. Subsequently, the mechanism of c-Myc transcription was investigated by using specific inhibitors to modulate c-Myc transcriptional activation. These compounds, obtained from the University of Arizona Cancer Center, attenuated cyclic-strain-induced c-Myc transcription by about 50%. Having established this reduction in expression, it was investigated how these effects modulate downstream genes that are regulated by c-Myc. The results indicate that direct targeting of the c-Myc promoter may decrease stretch-induced gene expression of vascular endothelial growth factor (VEGF), proliferating cell nuclear antigen (PCNA) and heat shock protein 60 (HSP60). These findings may help in the development of a novel therapeutic opportunity in vascular diseases.

La perturbation des écoulements au voisinage de la paroi artérielle équipée d'un stent joue un rôle prépondérant dans l'apparition et le développement des complications liées aux maladies cardiovasculaires (sténose, resténose, thrombose...). La topologie de l'écoulement dans ces régions est très complexe. En effet, au voisinage du stent, des zones de recirculation se forment en amont et aval de chaque branche et les contraintes pariétales y sont très faibles. Des études in vivo et in vitro ont mis en évidence le rôle de ces caractéristiques de l'écoulement intra-stent sur les maladies cardiovasculaires. Pour cela, la bonne estimation des contraintes pariétales et la compréhension du comportement de l'écoulement intra-stent et son rôle dans le transfert du principe actif devraient permettre d'optimiser les traitements (design de la prothèse, principe actif...). L'approche numérique est une voie très utile pour étudier ces phénomènes. Cependant, la bonne précision du calcul dépend du choix du modèle d'écoulement, des conditions aux limites, de la géométrie du stent et de l'artère pour réaliser une simulation pertinente.Nous étudions ici dans un premier temps l'effet du choix du modèle hémodynamique sur les caractéristiques de l'écoulement intra-stent. Trois modèles numériques décrivant l'écoulement coronaire ont été utilisés. Ces modèles sont : un modèle stationnaire "MP", le modèle pulsé simplifié "MPS" et le modèle pulsé complet "MPC" basé sur l'analyse de Womersley. Nous avons ainsi montré l'importance de la prise en compte de l'instationnarité de l'écoulement mais au dépens d'un temps de calcul très accru. Dans un second temps, nous étudions expérimentalement l'écoulement intra-stent en utilisant la technique de mesure "PIV". Cette étude expérimentale a permis de confirmer les résultats numériques précédents. Au final, nous examinons numériquement l'effet de la pulsatilitié de l'écoulement sur les flux massiques libérés par les faces d'une branche de stent actif. Cette étude numérique a mis en exergue l'importance du couplage entre les recirculations et le transfert de masse vers la paroi artérielle. / The disturbance of the flow in the vicinity of the arterial wall equipped with a stent plays a key role in the onset and development of complications related to cardiovascular diseases (stenosis, restenosis, thrombosis...). The topology of the flow field in the intra-stent zone is very complex. Indeed, in the vicinity of the stent, recirculation zones form upstream and downstream of the stent strut where wall shear stress is very low. In vivo and in vitro studies have demonstrated the role of the in-stent flow features on cardiovascular diseases.The correct estimation of the wall shear stress, the understanding of the behavior of the in-stent flow and its role in the transfer of the drug are expected to help optimize treatments (stent geometry, drug composition...). The numerical approach (CFD) is a useful and versatile way to study these phenomena. However, the accuracy and the relevance of the results depend on the choice of the flow model, the boundary conditions and the stent and artery geometry.Firstly we study in this work the impact of the hemodynamic model on the in-stent flow characteristics. Three numerical models describing the coronary flow are used. These models are: the steady model "MP", the simplified pulsatile model "MPS" and the complete pulsatile model "MPC" based on Womersley's analysis. We show the importance of the pulsatility of the flow but at the expense of a high increase in the computing time. Secondly we study experimentally the in-stent flow using measurement technique "PIV". This experimental study confirms the previous numerical results. Finally we examine numerically the effects of the flow pulsatility on the mass fluxes released by the faces of a drug eluting stent. This numerical study highlights the importance of the coupling between the recirculation zones and the mass transfer into the arterial wall.

京都大学 / 0048 / 新制・論文博士 / 博士(医学) / 乙第12999号 / 論医博第2107号 / 新制||医||1016(附属図書館) / 32927 / (主査)教授 川上 浩司, 教授 古川 壽亮, 教授 小池 薫 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・論文博士 / 博士(医学) / 乙第13207号 / 論医博第2161号 / 新制||医||1031(附属図書館) / (主査)教授 福原 俊一, 教授 湊谷 謙司, 教授 小池 薫 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

OBJECTIVES The aim of this analysis was to assess the 7-year long-term safety and effectiveness of a randomized comparison of percutaneous coronary intervention (PCI) with sirolimus-eluting stents (SES) versus minimally invasive direct coronary artery bypass (MIDCAB) surgery for the treatment of isolated proximal left anterior descending lesions. BACKGROUND Long-term follow-up data comparing PCI by SES and MIDCAB surgery for isolated proximal left anterior descending lesions are sparse. METHODS Patients were randomized either to PCI with SES (n ¼ 65) or MIDCAB (n ¼ 65). Follow-up data were obtained after 7 years with respect to the primary composite endpoint of death, myocardial infarction, and target vessel revas- cularization. Angina was assessed by the Canadian Cardiovascular Society classification and quality of life with Short Form 36 and MacNew quality of life questionnaires. RESULTS Follow-up was conducted in 129 patients at a median time of 7.3 years (interquartile range: 5.7, 8.3). There were no significant differences in the incidence of the primary composite endpoint between groups (22% PCI vs. 12% MIDCAB; p ¼ 0.17) or the endpoints death (14% vs. 17%; p ¼ 0.81) and myocardial infarction (6% vs. 9%, p ¼ 0.74). However, the target vessel revascularization rate was higher in the PCI group (20% vs. 1.5%; p < 0.001). Clinical symptoms and quality of life improved significantly from baseline with both interventions and were similar in magnitude between groups. CONCLUSIONS At 7-year follow-up, PCI by SES and MIDCAB in isolated proximal left anterior descending lesions yielded similar long-term outcomes regarding the primary composite clinical endpoint and quality of life. Target vessel revascularization was more frequent in the PCI group. (Randomied Comparison of Minimally Invasive Direct Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Proximal Stenosis of the Left Anterior Descending Coronary Artery; NCT00299429) (J Am Coll Cardiol Intv 2014;-:-–-) © 2014 by the American College of Cardiology Foundation.

Although the drug-eluting stent (DES) has dramatically reduced the rate of coronary restenosis, it still occurs in up to 20% of patients with a DES. Monitoring drug delivery could be one way to decrease restenosis rates. We demonstrate real-time photoacoustic imaging and spectroscopy (PAIS) using a wavelength-tunable visible laser and clinical ultrasound scanner to track cardiac drug delivery. The photoacoustic signal was initially calibrated using porcine myocardial samples soaked with a known concentration of a drug surrogate (Dil). Next, an in situ coronary artery was perfused with DiI for 20 min and imaged to monitor dye transport in the tissue. Finally, a partially DiI-coated stent was inserted into the porcine brachiocephalic trunk for imaging. The photoacoustic signal was proportional to the DiI concentration between 2.4 and 120 mu g/ml, and the dye was detected over 1.5 mm from the targeted coronary vessel. Photoacoustic imaging was also able to differentiate the DiI-coated portion of the stent from the uncoated region. These results suggest that PAIS can track drug delivery to cardiac tissue and detect drugs loaded onto a stent with sub-mm precision. Future work using PAIS may help improve DES design and reduce the probability of restenosis. (C) 2017 Society of Photo-Optical Instrumentation Engineers (SPIE)

Background: Drug eluting stents (DES) are preferred over bare metal stents (BMS) for native coronary artery revascularization unless contraindicated. However, the preferred stent choice for saphenous venous graft (SVG) percutaneous coronary interventions (PCI) is unclear due to conflicting results. Methods: PubMed, Clinical trials registry and the Cochrane Center Register of Controlled Trials were searched through June 2018. Seven studies (n = 1639) comparing DES versus BMS in SVG-PCI were included. Endpoints were major adverse cardiac events (MACE), cardiovascular mortality, all-cause mortality, myocardial infarction (MI), target vessel revascularization (TVR), target lesion revascularization (TLR), in-stent thrombosis, binary in-stent restenosis, and late lumen loss (LLL). Results: Overall, during a mean follow up of 32.1 months, there was no significant difference in the risk of MACE, cardiovascular mortality, all-cause mortality, MI, stent thrombosis, TVR and TLR between DES and BMS. However, short-term follow up (mean 11 months) showed lower rate of MACE (OR 0.66 [0.51, 0.85]; p = 0.002), TVR (OR 0.47 [0.23, 0.97]; p = 0.04) and binary in-stent restenosis (OR 0.14 [0.06, 0.37]; p < 0.0001) in DES as compared with BMS. This benefit was lost on long-term follow up with a mean follow up 35.5 months. Conclusion: In this meta-analysis of SVG-PCI, DES use was associated with similar MACE, cardiovascular mortality, all-cause mortality, MI, in-stent thrombosis, TVR and TLR compared with BMS during long-term follow up. There was high incidence of MACE noted in both DES and BMS suggesting a need for exploring novel strategies to treat SVG disease to improve clinical outcomes.